LRRC15 and telomere syndrome: We have demonstrated ABBV-085 monotherapy activity in all LRRC15 positive patient-derived xenograft (PDX) models of STS, even in highly chemo-refractive indications such as UPS (PDX; Supplementary Figure S1) with poor treatment options and survival [1].